The Prognostic Significance of the Lymph Node Ratio in Axillary Lymph Node Positive Breast Cancer

다국어 초록 (Multilingual Abstract)

Purpose: This study evaluated the prognostic impact of the lymph node ratio (LNR; i.e., the ratio of positive to dissected lymph nodes) on recurrence and survival in breast cancer patients with positive axillary lymph nodes (LNs). Methods: The study cohort was comprised of 330 breast cancer patients with positive axillary nodes who received postoperative radiotherapy between 1987 and 2004. Ten-year Kaplan-Meier locoregional failure, distant metastasis, disease-free survival (DFS) and disease-specific survival (DSS) rates were compared using Kaplan-Meier curves. The prognostic significance of the LNR was evaluated by multivariate analysis. Results: Median follow-up was 7.5years. By minimum p-value approach, 0.25 and 0.55 were the cutoff values of LNR at which most significant difference in DFS and DSS was observed. The DFS and DSS rates correlated significantly with tumor size, pN classification, LNR, histologic grade, lymphovascular invasion, the status of estrogen receptor and progesterone receptor. The LNR based classification yielded a statistically larger separation of the DFS curves than pN classification. In multivariate analysis, histologic grade and pN classification were significant prognostic factors for DFS and DSS. However, when the LNR was included as a covariate in the model, the LNR was highly significant (p<0.0001), and pN classification was not statistically significant (p>0.05). Conclusion: The LNR predicts recurrence and survival more accurately than pN classification in our study. The pN classification and LNR should be considered together in risk estimates for axillary LNs positive breast cancer patients.

참고문헌 (Reference)

1 김제연, "절제한 액와 림프절과 전이된 림프절의 비율이 액와부 전이 유방암 환자의 재발과 전체생존율에 미치는 영향" 한국유방암학회 11 (11): 194-200, 2008

2 Schaapveld M, "Variability in axillary lymph node dissection for breast cancer" 87 : 4-12, 2004

3 Voordeckers M, "The lymph node ratio as prognostic factor in node-positive breast cancer" 70 : 225-230, 2004

4 Chan JK, "The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients" 97 : 605-611, 2007

5 Kuru B, "The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma" 66 : 1328-1334, 2006

6 Forrest AP, "The Edinburgh randomized trial of axillary sampling or clearance after mastectomy" 82 : 1504-1508, 1995

7 Krag DN, "Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe" 2 : 335-339, 1993

8 Jatoi I, "Significance of axillary lymph node metastasis in primary breast cancer" 17 : 2334-2340, 1999

9 Grills IS, "Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes" 56 : 658-670, 2003

10 Lambah A, "Randomised study of axillary clearance versus four node sampling" 37 (37): 2-, 2001

11 De Ridder M, "Prognostic value of the lymph node ratio in node positive colon cancer" 55 : 1681-, 2006

12 Woodward WA, "Prognostic value of nodal ratios in node-positive breast cancer" 24 : 2910-2916, 2006

13 Kuru B, "Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma" 32 : 1082-1088, 2006

14 Greenstein AJ, "Prognostic significance of the number of lymph node metastases in esophageal cancer" 206 : 239-246, 2008

15 Wilking N, "Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group" 31 : 29-35, 1992

16 Hack TF, "Physical and psychological morbidity after axillary lymph node dissection for breast cancer" 17 : 143-149, 1999

17 Lale Atahan I, "Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer" 47 : 232-238, 2008

18 Chetty U, "Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit" 87 : 163-169, 2000

19 Vinh-Hung V, "Lymph node ratio as an alternative to pN staging in nodepositive breast cancer" 27 : 1062-1068, 2009

20 Veronesi U, "Distribution of axillary node metastases by level of invasion. An analysis of 539 cases" 59 : 682-687, 1987

21 van der Wal BC, "Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer" 28 : 481-489, 2002

22 Barranger E, "An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement" 91 : 113-119, 2005

23 Greene FL, "AJCC Cancer Staging Manual" Springer 223-236, 2002

24 Kiricuta CI, "A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma" 69 : 2496-2501, 1992

25 Farshid G, "A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node" 13 : 494-501, 2004